Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.34687 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.24157 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.24361 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.13575 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.16336 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.4184 | 54 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.40269 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.20874 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.17984 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.20137 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.24707 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.17232 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.29599 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.24114 | 51 |